Stock Information
Immunome Inc (IMNM)
Ticker Symbol: IMNM
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,109.34 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -2.4127
Revenue (TTM): $0.07 M
Dividend Yield: N/A%
ROE: -57.61%
Latest News
-
HC Wainwright & Co. Reiterates Buy on Immunome, Maintains $40 Price Target
Wed, May 13, 2026 7:11 AM
-
Immunome Q1 EPS $(0.48) Beats $(0.57) Estimate
Tue, May 12, 2026 5:05 PM
-
Immunome Reports First Quarter 2026 Financial Results and Provides Business Update
Tue, May 12, 2026 4:03 PM
Key Financials
Financial data not available